Core Insights - The stock of Yaoshi Technology increased by 2.68% on September 16, closing at 47.15 yuan, with a total of 6 block trades amounting to 2,164.44 million yuan [1][2] Trading Activity - The first trade occurred at a price of 42.44 yuan for 70,000 shares, totaling 2.97 million yuan, with a premium rate of -9.99% [1] - The second trade matched the first in price and volume, also at 42.44 yuan for 70,000 shares, totaling 2.97 million yuan, with the same premium rate [1] - The third trade involved 80,000 shares at 42.44 yuan, amounting to 3.40 million yuan, with a premium rate of -9.99% [1] - The fourth trade was for 70,000 shares at 42.44 yuan, totaling 2.97 million yuan, with a premium rate of -9.99% [1] - The fifth trade involved 140,000 shares at 42.44 yuan, totaling 5.94 million yuan, with a premium rate of -9.99% [2] - The sixth trade was for 80,000 shares at 42.44 yuan, amounting to 3.40 million yuan, with a premium rate of -9.99% [2] Recent Performance - Over the past three months, Yaoshi Technology has recorded a total of 24 block trades, with a cumulative transaction amount of 88.80 million yuan [2] - In the last five trading days, the stock has risen by 9.17%, with a net inflow of 217 million yuan from major funds [2]

Core Points - The announcement from Yaoshi Technology (300725) states that September 17 is the last conversion day for "Yaoshi Convertible Bonds" [1] - Investors holding "Yaoshi Convertible Bonds" can still convert their bonds before the market closes on September 17 [1] - After the market closes on September 17, unconverted "Yaoshi Convertible Bonds" will stop being convertible and will be forcibly redeemed at a price of 100.62 yuan per bond [1] - If forced redemption occurs, investors may face potential investment losses [1]

南京药石科技股份有限公司 关于药石转债即将停止转股暨赎回前最后一个交易日的 重要提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 | 证券代码：300725 | 证券简称：药石科技 | 公告编号：2025-090 | | --- | --- | --- | | 债券代码：123145 | 债券简称：药石转债 | | 截至 2025 年 9 月 16 日收市后，距离 2025 年 9 月 18 日（"药石转债"赎回 日）仅剩 1 个交易日。 2、债券持有人若转股，需开通创业板交易权限。投资者不符合创业板股票 适当性管理要求的，不能将所持"药石转债"转换为股票，特提请投资者关注不 能转股的风险。 3、特提醒"药石转债"持有人注意在限期内转股。 特别提示： 1、"药石转债"赎回价格：100.62 元/张（债券面值加当期应计利息，当期 年利率为 1.5%，且当期利息含税），扣税后的赎回价格以中国证券登记结算有 限责任公司深圳分公司（以下简称"中国结算"）核准的价格为准。 2、赎回条件满足日：2025 年 8 月 14 日 3、停止交易日：2025 年 9 月 ...

Core Points - The company Nanjing Yaoshi Technology Co., Ltd. announced that the "Yaoshi Convertible Bonds" will have its last conversion date on September 1, 2025 [1] - From September 18, 2025, the conversion will be halted, and a mandatory redemption will be implemented at a redemption price of 100.62 yuan per bond, which is below the current market price [1] - The total issuance amount of the convertible bonds is 1.15 billion yuan, and the redemption amount is expected to be credited by September 25, 2025 [1]

证券日报网讯药石科技（300725）9月15日在互动平台回答投资者提问时表示，截至2025年9月10日，公 司股东人数为47，205名。 ...

| 证券代码：300725 | 证券简称：药石科技 | 公告编号：2025-089 | | --- | --- | --- | | 债券代码：123145 | 债券简称：药石转债 | | 南京药石科技股份有限公司 关于药石转债赎回实施暨即将停止转股的重要提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 重要内容提示： 1、最后转股日：2025 年 9 月 17 日 2025 年 9 月 17 日收市前，持有"药石转债"的投资者仍可进行转股，2025 年 9 月 17 日收市后，未实施转股的"药石转债"将停止转股，剩余可转债将按 照 100.62 元/张的价格被强制赎回。若被强制赎回，投资者可能面临投资损失。 截至 2025 年 9 月 15 日收市后，距离 2025 年 9 月 18 日（"药石转债"赎回 日）仅剩 2 个交易日。 2、债券持有人若转股，需开通创业板交易权限。投资者不符合创业板股票 适当性管理要求的，不能将所持"药石转债"转换为股票，特提请投资者关注不 能转股的风险。 3、特提醒"药石转债"持有人注意在限期内转股。 特别提示： 1、" ...

Core Insights - The company maintains a "Buy" rating, reporting a revenue of 920 million yuan for H1 2025, representing a 23.48% increase, while net profit attributable to shareholders decreased by 26.54% to 72 million yuan [1] - The company is increasing investment in CMC resources to strengthen core customer relationships and market competitiveness, leading to revised EPS forecasts for 2025-2026 and a new forecast for 2027 [1] Revenue Performance - Revenue from drug research stage products and services was 154 million yuan, down 7.59%, with a gross margin of 57.29%, a decrease of 7.45 percentage points [2] - Revenue from drug development and commercialization stage products and services reached 765 million yuan, up 32.27%, with a gross margin of 25.69%, down 8.30 percentage points [2] Customer Structure and Order Growth - Revenue from Chinese customers was 261 million yuan, up 25.00%, while North American customers contributed 485 million yuan, up 8.65% [3] - The company has over 1,100 projects in early stages and 53 in clinical III and commercialization stages, with significant growth in new chemical entity orders and CDMO business [3] Catalysts - Order growth and capacity ramp-up are exceeding expectations, indicating strong future performance potential [4]

| 证券代码：300725 | 证券简称：药石科技 | 公告编号：2025-088 | | --- | --- | --- | | 债券代码：123145 | 债券简称：药石转债 | | 南京药石科技股份有限公司 关于控股股东、实际控制人及其一致行动人权益变动触及1%整数倍的公告 | 权益变动过程 | | | | 2025年8月30日至2025年9月12日诺维科思通过大宗交易方式减持公司股 份100,000股。在此期间，公司可转债转股10,213,760股，公司总股本从 220,376,063股上升至230,589,823股，受此影响，控股股东、实际控制人 | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | | | | | 及其一致行动人持股变动占公司总股本比例为0.92%。本次权益变动后， | | | | | | | | | 公司控股股东、实际控制人及其一致行动人合计持有的公司股份 | | | | | | | | | | 43,689,328股，持股比例由19.87%下降至18.95%，股份变动触及1%整数倍。 | | | | 股票简称 | ...

| 证券代码：300725 | 证券简称：药石科技 | 公告编号：2025-087 | | --- | --- | --- | | 债券代码：123145 | 债券简称：药石转债 | | 南京药石科技股份有限公司 关于药石转债赎回实施暨即将停止转股的重要提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 重要内容提示： 1、最后转股日：2025 年 9 月 17 日 2025 年 9 月 17 日收市前，持有"药石转债"的投资者仍可进行转股，2025 年 9 月 17 日收市后，未实施转股的"药石转债"将停止转股，剩余可转债将按 照 100.62 元/张的价格被强制赎回。若被强制赎回，投资者可能面临投资损失。 截至 2025 年 9 月 12 日收市后，距离 2025 年 9 月 18 日（"药石转债"赎回 日）仅剩 3 个交易日。 2．债券持有人若转股，需开通创业板交易权限。投资者不符合创业板股票 适当性管理要求的，不能将所持"药石转债"转换为股票，特提请投资者关注不 能转股的风险。 3．特提醒"药石转债"持有人注意在限期内转股。 特别提示： 1、" ...

Core Viewpoint - The stock of Yaoshi Technology has experienced fluctuations, with a recent decline of 2.00% and a total market value of 9.392 billion yuan, reflecting mixed investor sentiment and market activity [1]. Financial Performance - For the first half of 2025, Yaoshi Technology reported a revenue of 920 million yuan, representing a year-on-year growth of 23.48%. However, the net profit attributable to shareholders decreased by 26.54% to 72.498 million yuan [2]. - Since its A-share listing, the company has distributed a total of 231 million yuan in dividends, with 137 million yuan distributed over the past three years [3]. Stock Market Activity - As of September 12, the stock price of Yaoshi Technology was 42.62 yuan per share, with a trading volume of 2.42 billion yuan and a turnover rate of 2.96% [1]. - The stock has seen a year-to-date increase of 27.91%, but has declined by 3.60% over the last five trading days and 10.93% over the last twenty days [1]. Shareholder Information - As of July 18, the number of shareholders for Yaoshi Technology increased to 36,500, a rise of 7.33%, while the average number of circulating shares per person decreased by 6.83% to 4,621 shares [2]. - The sixth largest circulating shareholder is Hong Kong Central Clearing Limited, holding 2.1466 million shares, a decrease of 1.2259 million shares from the previous period [3].